As previously announced, on October 14, 2013, Savient Pharmaceuticals, Inc. (the
"Company") and its subsidiary, Savient Pharma Holdings, Inc. (collectively, the
"Debtors"), filed voluntary petitions (the "Chapter 11 Cases") for relief under
Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy
Court for the District of Delaware (the "Bankruptcy Court").

On April 17, 2014, the Debtors filed their monthly operating report for the
period of March 1, 2014 through March 31, 2014 (the "Monthly Operating Report")
with the Bankruptcy Court. The Monthly Operating Report is attached hereto as
Exhibit 99.1.

Cautionary Statement Regarding the Monthly Operating Report

The Company cautions investors and potential investors not to place undue
reliance upon the information contained in the Monthly Operating Report, which
was not prepared for the purpose of providing the basis for an investment
decision relating to any of the securities of the Company. The Monthly Operating
Report is limited in scope and has been prepared solely for the purpose of
complying with requirements of the Bankruptcy Court. The Monthly Operating
Report was not reviewed by independent accountants, is in a format prescribed by
applicable bankruptcy laws, and is subject to future adjustment. The financial
statements in the Monthly Operating Report are not prepared in accordance with
accounting principles generally accepted in the United States ("GAAP") and,
therefore, may exclude items required by GAAP, such as certain
reclassifications, eliminations, accruals, valuations and disclosures. The
Monthly Operating Report also contains information for periods which are shorter
or otherwise different from the historical periods required in the Company's
reports pursuant to the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and such information might not be indicative of the Company's
financial condition or operating results for a period that would be reflected in
the Company's financial statements or in its reports pursuant to the Exchange
Act. Information set forth in the Monthly Operating Report should not be viewed
as indicative of future results.

Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K and Exhibit 99.1 hereto (collectively, this
"Current Report") may contain "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995. Forward-looking statements
are those involving future events and future results that are based on current
expectations, estimates, forecasts, and projections as well as the current
beliefs and assumptions of the Company's management. Forward-looking statements
may be identified by words such as "anticipate," "estimate," "expect,"
"project," "intend," "plan," "believe," "may," "predict," "will," "would,"
"could," "should," "target" and similar expressions. All statements contained in
this Current Report that are not statements of historical fact and other
estimates, projections, future trends and the outcome of events that have not
yet occurred referenced in this Current Report should be considered
forward-looking statements. Actual results or events could differ materially
from those indicated in forward-looking statements as a result of risks and
uncertainties, including, among others, the potential adverse impact of the
Chapter 11 Cases on the Company's liquidity, changes in the Company's ability to
meet financial obligations during the Chapter 11 process or to maintain
contracts that are critical to the Company's wind-down of its affairs, the
outcome or timing of the Chapter 11 process, the effect of the Chapter 11 Cases
or the sale of substantially all of the Company's assets to Crealta
Pharmaceuticals LLC (the "Sale Transaction") on the Company's relationships with
third parties, regulatory authorities, employees and consultants in connection
with the Company's wind-down of its affairs, proceedings that may be brought by
third parties in connection with the Chapter 11 process, the ability of the
Company to fund the wind-down of its affairs and the timing or amount of any
distributions to the Company's stakeholders. For a discussion of some of the
additional risks and important factors that the Company believes could cause
actual results or events to differ from the forward-looking statements that it
makes, see the sections entitled "Risk Factors" and "Management's Discussion and
Analysis of Financial Condition and Results of Operations" in the Company's
Quarterly Report on Form 10-Q for the quarter ended September 30, 2013. In
addition, new risks and uncertainties emerge from time to time, and it is not
possible for the Company to predict or assess the impact of every factor that
may cause its actual results or events to differ from those contained in any
forward-looking statements. Accordingly, you should not place undue reliance on
any forward-looking statements contained in this Current Report. Any
forward-looking statements speak only as of the date of this Current Report. The
Company undertakes no obligation to publicly update forward-looking statements,
whether as a result of new information, future events or otherwise.

Limitation on Incorporation by Reference

In accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report is being furnished for informational purposes only and shall not
be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise
subject to the liabilities of that section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of

1933, as amended, except as otherwise expressly stated in such filing. The
filing of this current report (including Exhibit 99.1 attached hereto) will not
be deemed an admission as to the materiality of any information required to be
disclosed solely by Regulation FD.

Additional Information regarding the Chapter 11 Cases

Additional information regarding the Chapter 11 Cases is available at
www.gcginc.com/cases/svnt. This link is provided for convenience only. Such
information shall not be deemed to be incorporated by reference herein. As a
result of the consummation of the Sale Transaction, investors should no longer
refer to the Company's former company website for information.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

99.1 Monthly Operating Report for the Period of March 1, 2014 through
March 31, 2014, dated April 17, 2014.